Indefinite Delivery Contract EPD13055

The National Institute of Environmental Health Sciences, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a single-award indefinite delivery contract to Steinbeis GMBH & CO. KG FUR Technologietransfer with a potential value of $275,000. Under this contract, Steinbeis is providing human neural crest cell migration assay services in support of the agency's efforts to identify environmental compounds with potential for developmental...

The National Institute of Environmental Health Sciences awarded an indefinite delivery contract to BBD Biophenix SL to provide zebrafish assay services. Under the contract vehicle, NIEHS issued four firm fixed price delivery orders valued from $69,230 to $440,536 to the prime contractor for performance in Germany, Spain, and North Carolina. Services include zebrafish bioavailability assays, migration assays using human pluripotent stem cell-derived neural crest cells, and general zebrafish...

The National Institutes of Health National Institute of Environmental Health Sciences awarded a single award indefinite delivery contract to IUF - Leibniz-Institut Fur Umweltmedizinische Forschung GMBH for human neurosphere assay services and related products. The contract has a potential value of $1.3 million and a period of performance through June 2026. Two firm fixed price delivery orders have been awarded against the contract to date, for $406,412.40 and $369,796.88 respectively, to provide...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a single-award, indefinite delivery/indefinite quantity contract valued up to $100 million to SRI International of Menlo Park, California. The contract aims to develop animal models for the Biomedical Advanced Research and Development Authority's countermeasure programs against radiological and nuclear threats. Under the contract, SRI International was issued a $309,727...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030. Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed...

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...

This is an Indefinite Delivery Contract (IDC) awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit research organization. The contract has a ceiling value of $100,000,000 and a period of performance ending on September 30, 2021. The contract is for the development of animal models and medical countermeasures to support ASPR's Biological, Chemical, and...

The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...

The EPA's Office of Research and Development awarded a $7.8 million single-award Indefinite Delivery Contract (IDC) to Integrated Laboratory Systems, LLC (ILS), a subsidiary of Inotiv, Inc. This small business set-aside contract, which runs through January 2027, focuses on providing mammalian oral exposure studies to support the EPA's Center for Computational Toxicology and Exposure. Under this IDC, ILS has received multiple firm fixed-price delivery orders totaling over $1.5 million to...